Bleakley Financial Group »

Xeris Pharmaceuticals shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $32k 11k 2.85
2024-06-30 $27k 12k 2.25
2023-09-30 $21k 11k 1.86

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
NVIDIA Corporation (NVDA)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Bleakley Financial Group

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals